pre-IPO PHARMA

COMPANY OVERVIEW

ElevateBio, LLC, is a Cambridge-based biotechnology holding company, established to create and operate a broad portfolio of cell and gene therapy companies through partnerships with leading academic researchers, medical centers and entrepreneurs. ElevateBio builds single- and multi-product companies by providing scientific founders with fully-integrated bench-to- bedside capabilities including world-class scientists, manufacturing facilities, drug developers and commercial expertise. ElevateBio is building a team of industry leaders who work at the holding company and are assigned exclusively or in-part to ElevateBio portfolio companies over time. ElevateBio BaseCamp, a company-owned Center of Cell and Gene Therapy Innovation, will serve as the R&D, process development and manufacturing hub across the entire ElevateBio portfolio while also supporting selected strategic partners.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS


    WEBSITE

    https://www.elevate.bio


    CAREER WEBSITE

    https://www.elevate.bio/home#careers-1


    SOCIAL MEDIA


    INVESTORS

    ecor1-capital f2-ventures mpm-capital redmile-group samsara-biocapital


    PRESS RELEASES


    May 24, 2023

    ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth


    May 16, 2023

    ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting Highlighting Optimization of Processes for Viral Vector Production


    Mar 7, 2023

    ElevateBio Appoints Heidi L. Wagner, J.D., as Global Head of Government Affairs


    Jan 5, 2023

    ElevateBio to Present at the 41st Annual J.P. Morgan Healthcare Conference


    Nov 15, 2022

    ElevateBio and Affini-T Therapeutics Announce Partnership to Advance Affini-T's T Cell Therapy Programs Targeting Core Oncogenic Drivers


    For More Press Releases


    Google Analytics Alternative